The main objective of the Investment approach is to generate capital appreciation through investments in equities with a medium to long-term perspective.
Alpha (1Y) | Beta (1Y) | Standard Deviation (1Y) | % of +ve Months (SI) |
---|---|---|---|
2.77% | 0.90 | 13.54% | 56.47% |
Performance Table #
Trailing Returns (%) | 1m return | 3m return | 6m return | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
---|---|---|---|---|---|---|---|---|---|
Kotak AMC Pharma Fund | 4.65% | 13.89% | 23.37% | 54.91% | 19.77% | 18.97% | 21.31% | - | 13.93% |
NIFTY PHARMA | 1.32% | 9.38% | 14.57% | 28.49% | 15.73% | 16.15% | 16.64% | - | 14.42% |
QRC Report Card *
Strategy | Category | Fund Manager | Date of Inception | Age Of PMS | Corpus (in Cr, approx) | Benchmark | Returns SI (CAGR) | Stocks In Portfolio | Sectors In Portfolio |
---|---|---|---|---|---|---|---|---|---|
Kotak AMC Pharma Fund | Multi Cap | Anshul Saigal | 20 September 2016 | 7Y 5M | 26 | NIFTY PHARMA | 13.93% | 19 | 2 |
Portfolio Quality (Q) | Portfolio Risk (R) | Portfolio Consistency (C) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Index | Category Alpha (1Y) | Relative Alpha (1Y) |
% of +ve Months
(Fund Data) |
Alpha (1Y) | Beta (1Y) |
Standard Deviation (1Y)
(Fund Data) |
Sharpe Ratio (1Y)
(Fund Data) |
Alpha (SI) | Information Ratio (SI) | Consistency Ratio % |
Nifty 50 | 11.69% | -7.19% | 56.47% | 4.50% | 0.77 | 13.54% | 1.16 | -0.59% | -0.04 | 49.41 % |
Nifty 500 | 7.56% | -4.79% | 2.77% | 0.90 | -0.99% | -0.06 | 50.59 % | |||
Nifty Midcap 100 | -8.76% | -4.04% | -12.80% | 0.83 | -2.90% | -0.15 | 45.88 % | |||
Nifty Smallcap 100 | -13.69% | -4.1% | -17.79% | 0.72 | 0.90% | 0.04 | 45.88 % |
VIEW DETAILED QUALITY, RISK, CONSISTENCY ANALYSIS
Portfolio Holdings
Holding | % |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD | 16.00 |
DR REDDY'S LABORATORIES LTD | 12.40 |
CIPLA LTD | 12.00 |
LUPIN LTD | 6.10 |
IPCA LABORATORIES LTD | 5.80 |
FORTIS HEALTHCARE LTD | 5.40 |
ZYDUS LIFESCIENCES LTD | 5.00 |
ALKEM LABORATORIES LTD | 4.50 |
AJANTA PHARMA LTD | 3.90 |
AUROBINDO PHARMA LTD | 3.80 |
INDOCO REMEDIES LTD | 3.60 |
GLAND PHARMA LTD | 3.30 |
DIVI'S LABORATORIES LTD | 3.10 |
LAURUS LABS LTD | 2.90 |
TORRENT PHARMACEUTICALS LTD | 2.80 |
BIOCON LTD | 2.60 |
ALEMBIC PHARMACEUTICALS LTD | 2.50 |
DR LAL PATHLABS LTD | 1.50 |
CASH & CASH EQUIVALENT | 1.40 |
Top 18 Equity Holdings | 97.20 |
Sector Allocation
Holding | % |
---|---|
PHARMA & BIOTECHNOLOGY | 90.40 |
HEALTHCARE SERVICES | 6.90 |
Market Cap Allocation
Allocations | % |
---|---|
Large Cap | 48.6 |
Mid Cap | 40.0 |
Small Cap | 10.3 |
Cash | 2. |
Do Not Simply Invest, Make Informed Decisions
WISH TO MAKE INFORMED INVESTMENTS FOR LONG TERM WEALTH CREATION
Book a call with our PMS AIF SpecialistsDisclaimer
#Returns as of 29 Feb 2024. Returns up to 1 Year are absolute, above 1 Year are CAGR.
*QRC Report Card data is updated quarterly. Current data is as of Sep 23.